Stay updated on MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.

Latest updates to the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn administrative update adds revision v3.4.2 and removes v3.4.1 from the record history, with no impact on study data or user-facing functions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe Record History now shows a new revision entry v3.4.1 and removes the previous v3.4.0. This reflects an update to the study record’s version history.SummaryDifference0.1%

- Check27 days agoChange DetectedThe record history page now uses green highlights for additions and red highlights for deletions, adds a glossary toggle, and updates the version label to v3.4.0 with accompanying notes about color coding.SummaryDifference1%

- Check41 days agoChange DetectedNew revision entry v3.3.4 was added and the previous revision v3.3.3 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry (v3.3.3) is added, and the HHS Vulnerability Disclosure link along with the prior revision (v3.3.2) are removed. These updates are administrative and do not affect the study information.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision history shows addition of v3.3.2 and removal of v3.2.0, reflecting routine record-keeping rather than changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.